|
|
Volumn 18, Issue 12, 2007, Pages 3026-3030
|
|
Resolved: In minimizing kidney transplant immunosuppression, steroids should go before calcineurin inhibitors
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CALCINEURIN INHIBITOR;
CYCLOSPORIN;
DACLIZUMAB;
INTERLEUKIN 2 RECEPTOR ANTIBODY;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
POLYCLONAL ANTIBODY;
PREDNISONE;
RAPAMYCIN;
TACROLIMUS;
CALCINEURIN;
IMMUNOSUPPRESSIVE AGENT;
STEROID;
ADJUVANT THERAPY;
AVASCULAR NECROSIS;
CATARACT;
CLINICAL TRIAL;
CYTOMEGALOVIRUS INFECTION;
DIABETES MELLITUS;
DRUG WITHDRAWAL;
FRACTURE;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY GRAFT;
KIDNEY GRAFT REJECTION;
LONG TERM CARE;
LYMPHOPROLIFERATIVE DISEASE;
NEUROTOXICITY;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
REVIEW;
SHORT COURSE THERAPY;
DRUG ADMINISTRATION;
DRUG ANTAGONISM;
GRAFT SURVIVAL;
KIDNEY DISEASE;
KIDNEY TRANSPLANTATION;
LIVING DONOR;
METABOLISM;
METHODOLOGY;
NOTE;
RANDOMIZED CONTROLLED TRIAL;
RECURRENT DISEASE;
CALCINEURIN;
DRUG ADMINISTRATION SCHEDULE;
GRAFT SURVIVAL;
HUMANS;
IMMUNOSUPPRESSION;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY DISEASES;
KIDNEY TRANSPLANTATION;
LIVING DONORS;
PREDNISONE;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RECURRENCE;
STEROIDS;
TRANSPLANTATION CONDITIONING;
|
|
EID: 36849044594
PISSN: 10466673
EISSN: None
Source Type: Journal
DOI: 10.1681/ASN.2007060662 Document Type: Review |
|
Times cited : (5)
|
|
References (0)
|
